John F. Kurtzke
John F. Kurtzke was an American neurologist renowned for his contributions to the study of multiple sclerosis (MS). He is best known for developing the Kurtzke Expanded Disability Status Scale (EDSS), a method of quantifying disability in multiple sclerosis and monitoring changes in the level of disability over time.
Early Life and Education[edit]
John F. Kurtzke was born on December 14, 1926. He pursued his medical education at Cornell University, where he earned his medical degree. Following his graduation, Kurtzke completed his residency in neurology, which laid the foundation for his future research and clinical work.
Career[edit]
Kurtzke's career was primarily focused on the epidemiology and clinical aspects of multiple sclerosis. He held various academic and clinical positions throughout his career, contributing significantly to the understanding of MS.
Kurtzke Expanded Disability Status Scale (EDSS)[edit]
One of Kurtzke's most notable achievements is the development of the Kurtzke Expanded Disability Status Scale (EDSS). The EDSS is a method used by neurologists to quantify disability in multiple sclerosis and to monitor changes in the level of disability over time. The scale ranges from 0 to 10, with higher scores indicating greater disability.
Contributions to Multiple Sclerosis Research[edit]
Kurtzke's work extended beyond the development of the EDSS. He conducted extensive research on the epidemiology of multiple sclerosis, contributing to the understanding of its distribution and prevalence. His research helped to identify various environmental and genetic factors associated with the disease.
Awards and Recognition[edit]
Throughout his career, Kurtzke received numerous awards and honors for his contributions to neurology and multiple sclerosis research. His work has had a lasting impact on the field, and he is widely regarded as a pioneer in the study of MS.
Personal Life[edit]
John F. Kurtzke was married and had children. He passed away on December 1, 2015, leaving behind a legacy of significant contributions to the field of neurology.
See Also[edit]
References[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
